Structure Therapeutics Inc ADR (NASDAQ:GPCR)’s traded shares stood at 0.74 million during the last session, with the company’s beta value hitting -1.78. At the close
In the last trading session, 1.39 million Structure Therapeutics Inc ADR (NASDAQ:GPCR) shares changed hands as the company’s beta touched -1.72. With the company’s per
Structure Therapeutics Inc ADR (NASDAQ:GPCR) has a beta value of -1.72 and has seen 2.08 million shares traded in the last trading session. The company,
During the recent session, Structure Therapeutics Inc ADR (NASDAQ:GPCR)’s traded shares were 1.35 million, with the beta value of the company hitting -1.37. At the
Structure Therapeutics Inc ADR (NASDAQ:GPCR)’s traded shares stood at 0.51 million during the last session, with the company’s beta value hitting -0.98. At the close
Structure Therapeutics Inc ADR (NASDAQ:GPCR)’s traded shares stood at 1.82 million during the last session, with the company’s beta value hitting -0.51. At the close
Structure Therapeutics Inc ADR (NASDAQ:GPCR) has a beta value of -1.46 and has seen 2.06 million shares traded in the last trading session. The company,
Structure Therapeutics Inc ADR (NASDAQ:GPCR) has a beta value of -1.46 and has seen 0.55 million shares traded in the recent trading session. The company,
During the last session, Structure Therapeutics Inc ADR (NASDAQ:GPCR)’s traded shares were 0.45 million, with the beta value of the company hitting -1.88. At the
Structure Therapeutics Inc ADR (NASDAQ:GPCR)’s traded shares stood at 0.41 million during the last session, with the company’s beta value hitting -1.98. At the close
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
